Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.
Significant work in animal models combined with compelling studies in human patients together have begun to provide a higher resolution picture of how the immune system regulates cancer development. Currently, this immune system-tumor interaction is represented by the concept of cancer immunoediting, which emphasizes that immunity may subserve either classical cancer immunosurveillance functions or promote the eventual outgrowth of immunoevasive cancer cells. One important line of evidence supporting an immunosurveillance process in humans has been the finding that the presence of distinct profiles of TILs may be correlated with improved clinical outcomes in a subset of human cancers. However, the contribution of TILs to the natural history of gliomas is less clear. Moreover, understanding the relationship between TILs and cancers of the brain is particularly challenging because our understanding of how immune responses develop in the central nervous systems is still evolving. In this review, we will first provide an overview of three important themes in the central nervous system anti-tumor immunity--i.e., antigen expression, how antigen may be presented, and lymphocyte trafficking--and subsequently discuss the extant work on TILs in glioma.
Dunn
Gavin P
GP
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. gpdunn@partners.org
Dunn
Ian F
IF
Curry
William T
WT
D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D053842:Microsatellite Instability; D011379:Prognosis; D016019:Survival Analysis
D015395:Histocompatibility Antigens Class I
N Engl J Med. 2005 Dec 22;353(25):2654-66
16371631
Clin Cancer Res. 2000 Jan;6(1):102-11
10656438
J Immunol. 2007 May 15;178(10):6038-42
17475827
Int J Cancer. 1999 Dec 10;83(6):760-4
10597192
N Engl J Med. 2003 Jan 16;348(3):203-13
12529460
Tissue Antigens. 2002 Oct;60(4):319-27
12472661
Br J Cancer. 1982 Jan;45(1):61-9
6174136
J Natl Cancer Inst. 1989 Dec 20;81(24):1893-904
2593166
Acta Neuropathol. 1997 May;93(5):518-27
9144591
J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9
11895036
Nat Med. 2005 Mar;11(3):328-34
15735653
Annu Rev Immunol. 1994;12:337-65
8011285
Nat Immunol. 2002 Nov;3(11):991-8
12407406
Mol Med. 2000 May;6(5):440-9
10952023
J Neuroimmunol. 1999 Dec;100(1-2):216-32
10695732
Acta Neuropathol. 1996 Sep;92(3):288-93
8870831
Cancer Res. 1998 Aug 15;58(16):3491-4
9721846
Clin Cancer Res. 2002 Sep;8(9):2851-5
12231526
Trends Immunol. 2007 Jan;28(1):5-11
17140851
J Neurosurg. 1978 Dec;49(6):854-61
731302
J Neurooncol. 1999;45(2):141-57
10778730
Neuro Oncol. 2005 Apr;7(2):122-33
15831231
J Immunol. 2004 Aug 15;173(4):2353-61
15294948
J Immunother. 2003 Mar-Apr;26(2):107-16
12616102
Cancer Res. 2003 Oct 15;63(20):6962-70
14583498
Semin Cancer Biol. 2004 Jun;14(3):171-9
15246052
Am J Physiol. 1981 Apr;240(4):F329-36
7223890
J Immunol. 2002 Nov 15;169(10):5415-23
12421916
Immunity. 1999 Mar;10(3):281-7
10204484
Science. 1991 Dec 13;254(5038):1643-7
1840703
Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):566-75
17255279
J Neurosci Res. 1991 Feb;28(2):254-60
2033653
Acta Neuropathol. 1976;35(3):265-71
181941
Oncogene. 2006 May 4;25(19):2801-6
16407848
J Immunother. 2003 Jul-Aug;26(4):301-12
12843792
Am J Pathol. 1997 Jun;150(6):2143-52
9176405
Cancer Res. 2001 Feb 1;61(3):842-7
11221866
Br J Cancer. 2007 Apr 23;96(8):1293-301
17375044
Neoplasia. 2005 Aug;7(8):717-22
16207473
Nat Med. 2004 Sep;10(9):942-9
15322536
Trends Mol Med. 2007 Mar;13(3):108-16
17257897
Kurume Med J. 1997;44(1):43-51
9154761
Neurochem Int. 2006 Jul;49(2):195-203
16730862
Cancer Res. 2005 Jul 1;65(13):5740-9
15994949
Curr Top Microbiol Immunol. 2006;298:121-38
16329186
J Neurooncol. 2007 Jan;81(2):139-48
17004103
Brain. 2006 Sep;129(Pt 9):2416-25
16891318
N Engl J Med. 2005 Nov 10;353(19):2012-24
16282176
Surg Neurol. 1985 Mar;23(3):221-6
2983448
Neuro Oncol. 2006 Jul;8(3):234-43
16723631
Int J Cancer. 2005 Nov 10;117(3):456-9
15906353
Neuro Oncol. 2002 Oct;4(4):278-99
12356358
J Biol Chem. 2002 Dec 20;277(51):49481-7
12388552
Cancer Res. 1981 Feb;41(2):361-75
7004632
Br J Cancer. 2002 Oct 21;87(9):1006-12
12434293
Endocr Relat Cancer. 2001 Jun;8(2):83-96
11397666
Immunity. 2004 Aug;21(2):137-48
15308095
Int J Cancer. 2002 Mar 1;98(1):73-7
11857388
J Immunol. 2006 Dec 15;177(12):8448-55
17142742
Brain Pathol. 1993 Jan;3(1):19-26
8269081
Trends Immunol. 2005 Sep;26(9):485-95
16039904
Acta Neuropathol. 1990;80(3):287-94
2399810
J Neurooncol. 2005 Sep;74(3):287-93
16132525
Am J Physiol. 1983 Dec;245(6):R853-9
6660332
Acta Neuropathol. 1987;74(3):269-77
3314311
Nat Rev Immunol. 2006 May;6(5):383-93
16622476
J Neurooncol. 2000 Oct-Nov;50(1-2):99-108
11245285
Cancer Res. 2004 Jul 15;64(14):4980-6
15256472
Clin Cancer Res. 2000 Oct;6(10):3916-22
11051238
J Neurooncol. 2003 Aug-Sep;64(1-2):55-61
12952286
Proc Natl Acad Sci U S A. 1978 Oct;75(10):5122-6
283420
Adv Exp Med Biol. 2007;590:103-11
17191380
Cytogenet Cell Genet. 2001;94(3-4):131-6
11856869
Brain Tumor Pathol. 2004;21(1):35-8
15696967
Cancer Res. 2004 Jul 15;64(14):4973-9
15256471
Cancer Res. 2000 Mar 1;60(5):1168-72
10728667
Nat Rev Immunol. 2003 Jul;3(7):569-81
12876559
Clin Cancer Res. 2005 Feb 15;11(4):1462-6
15746047
J Neurosurg. 1988 Mar;68(3):432-7
2830373
Clin Neuropathol. 1984 Jul-Aug;3(4):143-7
6478676
Cancer Res. 1989 Apr 1;49(7):1843-9
2784352
J Mol Med (Berl). 2006 Jul;84(7):532-43
16773356
Br J Exp Pathol. 1948 Feb;29(1):58-69
18865105
Immunity. 2005 Feb;22(2):175-84
15723806
Brain. 1971;94(1):117-24
5552158
Eur J Immunol. 2004 Nov;34(11):2955-63
15376193
Cancer Immun. 2007;7:4
17311363
Cancer Immun. 2003 Dec 12;3 Suppl 2:1
15022367
Adv Cancer Res. 2003;90:127-56
14710949
Oncologist. 2006 Feb;11(2):165-80
16476837
Trends Pharmacol Sci. 2006 Jan;27(1):48-55
16310865
Cancer Cell. 2007 Jan;11(1):83-95
17222792
J Neurosurg. 1984 Jun;60(6):1138-47
6374063
Science. 2006 Sep 29;313(5795):1960-4
17008531
J Transl Med. 2006 Mar 30;4:15
16573834
Adv Immunol. 1977;25:1-54
345773
J Neurosurg. 1970 Feb;32(2):127-44
5411991
J Neurol Neurosurg Psychiatry. 1983 Aug;46(8):734-7
6193251
J Immunother. 2000 Sep-Oct;23(5):511-8
11001544
Cancer. 1996 Apr 1;77(7):1303-10
8608507
Ann Neurol. 1978 Sep;4(3):219-24
718133
Neurosurgery. 1986 Jun;18(6):766-72
3488516
Cancer Immunol Immunother. 2005 Mar;54(3):187-207
15309328
N Engl J Med. 2005 Mar 10;352(10):987-96
15758009
Int J Cancer. 1993 May 28;54(3):527-8
8509230
Oncogene. 2004 Feb 19;23(7):1420-7
14691456
J Neurooncol. 2006 Jan;76(1):23-30
16155724
Cancer. 2006 Sep 15;107(6):1407-18
16902988
Immunol Today. 1992 Dec;13(12):507-12
1463583
Clin Cancer Res. 2005 Jun 1;11(11):4160-7
15930352
Nat Rev Cancer. 2005 Aug;5(8):615-25
16034368
J Immunother. 2004 May-Jun;27(3):220-6
15076139
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12445-50
8901601
Oncogene. 2001 Jul 12;20(31):4107-14
11464277
Acta Neuropathol. 1989;78(2):189-93
2750489
J Neurooncol. 2007 Jun;83(2):121-31
17077937
J Surg Oncol. 1998 Oct;69(2):99-104
9808513
Surg Neurol. 1988 Jun;29(6):435-42
3259730
J Neurosurg. 1979 Mar;50(3):298-304
217977
Brain Pathol. 1991 Jan;1(2):97-105
1669702
Clin Cancer Res. 2007 Feb 15;13(4):1253-9
17317837
Acta Neurochir Suppl (Wien). 1979;28(2):485-8
225937
J Invest Dermatol. 2002 Apr;118(4):600-5
11918705
Immunology. 2002 Sep;107(1):28-38
12225360
J Immunol. 2003 Sep 1;171(5):2187-91
12928361
Cancer. 1988 Feb 15;61(4):738-43
3338036
Nature. 1998 Mar 19;392(6673):245-52
9521319
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43
16344461
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6879-84
10359807
Nature. 2005 Aug 25;436(7054):1186-90
15995699
Semin Oncol. 2006 Jun;33(3):270-98
16769417
Neuro Oncol. 1999 Jan;1(1):44-51
11550301
Clin Exp Immunol. 2001 Nov;126(2):206-13
11703362
J Neurosurg. 1979 Mar;50(3):305-11
422981
Annu Rev Immunol. 2004;22:329-60
15032581
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):639-44
12515857
Tumori. 1979 Feb 28;65(1):119-25
220763
Clin Cancer Res. 1999 May;5(5):1107-13
10353745
J Neurosurg. 1989 Oct;71(4):528-33
2795172
Neurochem Int. 2006 Oct;49(5):423-32
16621164
Nature. 2001 Apr 26;410(6832):1107-11
11323675
Neuro Oncol. 2006 Jul;8(3):261-79
16775224
Cancer Res. 2001 Jun 15;61(12):4766-72
11406550
J Neural Transm (Vienna). 2006 Apr;113(4):477-85
16550326
Cancer Res. 1988 Dec 1;48(23):6926-32
3052809
Curr Opin Immunol. 2007 Apr;19(2):203-8
17292599
Trends Neurosci. 2001 Dec;24(12):719-25
11718877
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14608-13
11121063
J Exp Med. 1998 Jan 19;187(2):265-70
9432985
J Neurooncol. 1993 Sep;17(3):261-71
7513019
Invest New Drugs. 2004 Jan;22(1):27-37
14707492
Semin Cancer Biol. 2006 Oct;16(5):348-58
16893656
Lab Invest. 1996 Jan;74(1):43-7
8569196
Neurosurgery. 2003 Jul;53(1):144-52; discussion 152-3
12823883
J Neurooncol. 2003 Aug-Sep;64(1-2):3-11
12952281
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3
8524854